Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Bone Marrow Transplantation|March 21, 2019
Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patientsAngela Granata, Sabine Fürst, Stefania Bramanti, et al.
Haematologica|April 28, 2018
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantationAlessandra Roberto, Clara Di Vito, Elisa Zaghi, et al.
Transplantation and Cellular Therapy|April 5, 2021
Feasibility and Efficacy of CD45RA+ Depleted Donor Lymphocytes Infusion After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Patients With Hematological MalignanciesLuca Castagna, Viviana Valli, Inna Timofeeva, et al.
Blood|August 6, 2011
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patientsGiuseppe Visani, Lara Malerba, Pietro Maria Stefani, et al.
Blood|March 12, 2010
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availabilityBarbara Sarina, Luca Castagna, Lucia Farina, et al.
Blood|March 7, 2015
Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantationAlessandra Roberto, Luca Castagna, Veronica Zanon, et al.
Transplantation and Cellular Therapy|December 26, 2021
Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation CyclophosphamideJacopo Mariotti, Faezeh Legrand, Sabine Furst, et al.
Expert Opinion on Biological Therapy|May 17, 2017
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?Francesca Patriarca, Luisa Giaccone, Francesco Onida, et al.
Bone Marrow Transplantation|November 16, 2020
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcomeLuca Castagna, Thomas Pagliardini, Stefania Bramanti, et al.
Blood Advances|April 1, 2020
Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphomaChiara De Philippis, Faezeh Legrand-Izadifar, Stefania Bramanti, et al.
Pageof 7